| scholarly article | Q13442814 |
| P50 | author | David J. Conway | Q30347162 |
| P2093 | author name string | H C Whittle | |
| D J C Miles | |||
| Duah, N.O. | |||
| Miles, J.C. | |||
| N O Duah | |||
| Whittle, H.D. | |||
| P2860 | cites work | Serum IgG3 to the Plasmodium falciparum merozoite surface protein 2 is strongly associated with a reduced prospective risk of malaria | Q39247931 |
| Plasmodium falciparum merozoite surface protein 3 is a target of allele-specific immunity and alleles are maintained by natural selection | Q39362543 | ||
| High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal Kenya | Q39362550 | ||
| Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malaria | Q39362569 | ||
| Differential patterns of human immunoglobulin G subclass responses to distinct regions of a single protein, the merozoite surface protein 1 of Plasmodium falciparum | Q39518517 | ||
| Human antibody response to Plasmodium falciparum merozoite surface protein 2 is serogroup specific and predominantly of the immunoglobulin G3 subclass | Q39823427 | ||
| Identification of a conserved region of Plasmodium falciparum MSP3 targeted by biologically active antibodies to improve vaccine design | Q40491236 | ||
| A longitudinal investigation of IgG and IgM antibody responses to the merozoite surface protein-1 19-kiloDalton domain of Plasmodium falciparum in pregnant women and infants: associations with febrile illness, parasitemia, and anemia. | Q40640896 | ||
| Mortality and morbidity from malaria among children in a rural area of The Gambia, West Africa | Q40801749 | ||
| Effects of foetal haemoglobin on susceptibility of red cells to Plasmodium falciparum | Q40831810 | ||
| STUDIES IN THE ACQUISITION OF IMMUNITY OF PLASMODIUM FALCIPARUM INFECTIONS IN AFRICA. | Q41944135 | ||
| Antibodies against Plasmodium falciparum vaccine candidates in infants in an area of intense and perennial transmission: relationships with clinical malaria and with entomological inoculation rates | Q43952320 | ||
| Pattern of immunoglobulin isotype response to Plasmodium falciparum blood-stage antigens in individuals living in a holoendemic area of Senegal (Dielmo, west Africa). | Q44710649 | ||
| Opsonization as an effector mechanism in human protection against asexual blood stages of Plasmodium falciparum: Functional role of IgG subclasses | Q46370720 | ||
| Antibody responses to a panel of Plasmodium falciparum malaria blood-stage antigens in relation to clinical disease outcome in Sudan. | Q46682906 | ||
| IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): increasing prevalence with age and association with clinical immunity to malaria. | Q47830190 | ||
| A longitudinal study of type-specific antibody responses to Plasmodium falciparum merozoite surface protein-1 in an area of unstable malaria in Sudan. | Q47832886 | ||
| Naturally acquired immunoglobulin (Ig)G subclass antibodies to crude asexual Plasmodium falciparum lysates: evidence for association with protection for IgG1 and disease for IgG2. | Q47900627 | ||
| Lack of association between levels of transplacentally acquired Plasmodium falciparum-specific antibodies and age of onset of clinical malaria in infants in a malaria endemic area of Nigeria | Q48033641 | ||
| Correlations between treatment outcome and both anti-MSP119 antibody response and erythrocyte-related genetic factors in Plasmodium falciparum malaria. | Q48033784 | ||
| Expression of the 19-kilodalton carboxy-terminal fragment of the Plasmodium falciparum merozoite surface protein-1 in Escherichia coli as a correctly folded protein. | Q54638975 | ||
| Cytophilic antibodies to Plasmodium falciparum glutamate rich protein are associated with malaria protection in an area of holoendemic transmission | Q24815535 | ||
| Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3. | Q33305467 | ||
| Analysis of human antibodies to erythrocyte binding antigen 175 of Plasmodium falciparum | Q33591313 | ||
| Lack of association between maternal antibody and protection of African infants from malaria infection | Q33592503 | ||
| Levels of antibody to conserved parts of Plasmodium falciparum merozoite surface protein 1 in Ghanaian children are not associated with protection from clinical malaria. | Q33866742 | ||
| High immunoglobulin G2 (IgG2) and low IgG4 levels are associated with human resistance to Plasmodium falciparum malaria | Q34003525 | ||
| Purification, characterization, and immunogenicity of the refolded ectodomain of the Plasmodium falciparum apical membrane antigen 1 expressed in Escherichia coli | Q34122492 | ||
| Epitope-specific regulation of immunoglobulin class switching in mice immunized with malarial merozoite surface proteins | Q34194702 | ||
| Target antigen, age, and duration of antigen exposure independently regulate immunoglobulin G subclass switching in malaria | Q34301187 | ||
| Analysis of human antibodies to erythrocyte binding antigen 175 peptide 4 of Plasmodium falciparum | Q34537136 | ||
| Natural immune response to the C-terminal 19-kilodalton domain of Plasmodium falciparum merozoite surface protein 1. | Q35505807 | ||
| Antibodies elicited in adults by a primary Plasmodium falciparum blood-stage infection recognize different epitopes compared with immune individuals | Q35901099 | ||
| Naturally acquired antibodies to polymorphic and conserved epitopes of Plasmodium falciparum merozoite surface protein 3. | Q35990786 | ||
| Association between protection against clinical malaria and antibodies to merozoite surface antigens in an area of hyperendemicity in Myanmar: complementarity between responses to merozoite surface protein 3 and the 220-kilodalton glutamate-rich pro | Q36227049 | ||
| Humoral responses to plasmodium falciparum blood-stage antigens and association with incidence of clinical malaria in children living in an area of seasonal malaria transmission in Burkina Faso, West Africa. | Q36421572 | ||
| Duration of naturally acquired antibody responses to blood-stage Plasmodium falciparum is age dependent and antigen specific | Q36539692 | ||
| Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria | Q36594057 | ||
| Cohort study of the association of antibody levels to AMA1, MSP119, MSP3 and GLURP with protection from clinical malaria in Ghanaian children | Q36862490 | ||
| Plasmodium falciparum malaria: evidence for an isotype imbalance which may be responsible for delayed acquisition of protective immunity | Q36943252 | ||
| Changes in malaria indices between 1999 and 2007 in The Gambia: a retrospective analysis | Q37023452 | ||
| Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness | Q37099503 | ||
| Antibodies to the N-terminal block 2 of plasmodium falciparum merozoite surface protein 1 are associated with protection against clinical malaria | Q37582802 | ||
| Isotypic analysis of maternally transmitted Plasmodium falciparum-specific antibodies in Cameroon, and relationship with risk of P. falciparum infection. | Q38969542 | ||
| Risk of severe malaria among African infants: direct evidence of clinical protection during early infancy | Q39115713 | ||
| P433 | issue | 2 | |
| P921 | main subject | Plasmodium falciparum | Q311383 |
| adaptive immune system | Q1645075 | ||
| Antibody Isotypes for Tumor Immunotherapy | Q42660171 | ||
| birth cohort | Q64532946 | ||
| P304 | page(s) | 125-134 | |
| P577 | publication date | 2010-01-01 | |
| 2010-02-01 | |||
| P1433 | published in | Parasite Immunology | Q15751559 |
| P1476 | title | Acquisition of antibody isotypes against Plasmodium falciparum blood stage antigens in a birth cohort | |
| P478 | volume | 32 |
| Q34487139 | A combined analysis of immunogenicity, antibody kinetics and vaccine efficacy from phase 2 trials of the RTS,S malaria vaccine |
| Q37285306 | Acquisition of natural humoral immunity to P. falciparum in early life in Benin: impact of clinical, environmental and host factors |
| Q35739071 | Age-dependent IgG subclass responses to Plasmodium falciparum EBA-175 are differentially associated with incidence of malaria in Mozambican children |
| Q47996539 | Antibody response to allelic variants of 19kDa fragment of MSP-1: recognition of a variant and protection associated with ethnicity in Assam, India |
| Q61445471 | Comparative analysis of IgG and IgG subclasses against Plasmodium falciparum MSP-1 in children from five contrasting bioecological zones of Cameroon |
| Q36555103 | Contrasting Patterns of Serologic and Functional Antibody Dynamics to Plasmodium falciparum Antigens in a Kenyan Birth Cohort |
| Q37597307 | Development of Plasmodium falciparum specific naïve, atypical, memory and plasma B cells during infancy and in adults in an endemic area |
| Q35903025 | Developmental allometry and paediatric malaria |
| Q44164631 | Differential acquisition of human antibody responses to Plasmodium falciparum according to intensity of exposure to Anopheles bites |
| Q34778078 | Effect of transmission intensity and age on subclass antibody responses to Plasmodium falciparum pre-erythrocytic and blood-stage antigens |
| Q33754553 | Epstein-Barr virus but not cytomegalovirus is associated with reduced vaccine antibody responses in Gambian infants |
| Q40432296 | Evaluation of Immunoglobulin G Responses to Plasmodium falciparum and Plasmodium vivax in Malian School Children Using Multiplex Bead Assay |
| Q64136478 | Investigation of a case of suspected transfusion-transmitted malaria |
| Q52591414 | Malaria incidence and prevalence during the first year of life in Nanoro, Burkina Faso: a birth-cohort study. |
| Q40082124 | Mother-Newborn Pairs in Malawi Have Similar Antibody Repertoires to Diverse Malaria Antigens |
| Q35076906 | Natural antibody response to Plasmodium falciparum merozoite antigens MSP5, MSP9 and EBA175 is associated to clinical protection in the Brazilian Amazon |
| Q92664225 | Plasmodium falciparum merozoite surface antigen-specific cytophilic IgG and control of malaria infection in a Beninese birth cohort |
| Q26315542 | Plasmodium malaria and antimalarial antibodies in the first year of life |
| Q34092432 | Pre-clinical assessment of novel multivalent MSP3 malaria vaccine constructs |
| Q50098404 | Selecting analytical biomarkers for diagnostic applications: a first principles approach |
| Q36569534 | Strain-transcending immune response generated by chimeras of the malaria vaccine candidate merozoite surface protein 2. |
| Q36728063 | Targets and Mechanisms Associated with Protection from Severe Plasmodium falciparum Malaria in Kenyan Children |
Search more.